anthrax immune globulin (Anthrasil) Report issue

Active Ingredient History

  • Now
Anthrax immune globulin, tradename Anthrasil, is a human immune globulin that is used in combination with antibiotics to treat anthrax. It was developed by Cangene and purchased in 2011 by the Biomedical Advanced Research and Development Authority (BARDA) under Project Bioshield. On 24 March 2015 it was granted approval by the United States Food and Drug Administration for use in treating inhalation anthrax in conjunction with antibiotics.   Wikipedia

More Chemistry
aigiv antibodies | anthrasil | anthrax immune globulin | anthrax immune globulin intravenous | anthrax immune globulin intravenous (human) | anthrivig


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue